Drug News: Finacea, FluMist, IntanzaFinacea: new topical treatment for rosacea; FluMist: first intranasal flu vaccine; Intanza: first intradermal flu vaccine. Making the gradeTech takes on teaching duties. Editorial: How do you like your innovation? In these uncertain times, be open to new ideas, wherever they originate. Letter: Questioning the role of DPP-4 inhibitors A reader comments on the role of DPP-4 inhibitors in the management of type 2 diabetes. Tech Refresher: Easing the pain of migraine The more pharmacy technicians know about migraines, the more likely they are to be able to identify patients who could benefit from consulting with the pharmacist. Tech regulation moving forward BC College unlikely to back away from regulation, despite petition signed by 500 pharmacists. Letter: What do pharmacists want? Why are we providing our professional services for less than it costs to cover our expenses? Divulge personal health to colleges only: CMPA Shock value: ECT here to stay New Canadian position paper says there’s still a place for the controversial psychiatric treatment Barriers to care differ between FPs, psychiatrists First Previous 1122 1123 1124 1125 1126 Next Last
